XML 348 R68.htm IDEA: XBRL DOCUMENT
v3.23.1

Investments held at fair value - Narrative (Details) $ in Thousands |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 Months Ended | 5 Months Ended | 12 Months Ended |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Aug. 22, 2022 shares | May 25, 2022 USD ($) shares | Jan. 13, 2022 USD ($) shares | Nov. 10, 2021 shares | Nov. 09, 2021 USD ($) shares | May 25, 2021 USD ($) shares | May 24, 2021 | Feb. 10, 2021 shares | Feb. 09, 2021 USD ($) shares | Jan. 08, 2021 USD ($) shares | Aug. 26, 2020 USD ($) shares | Jun. 30, 2020 USD ($) shares | May 26, 2020 USD ($) shares | Apr. 30, 2020 USD ($) shares | Apr. 01, 2020 USD ($) shares | Feb. 12, 2020 USD ($) shares | Jan. 22, 2020 USD ($) shares | Sep. 30, 2022 USD ($) | Dec. 31, 2022 USD ($) shares | Dec. 31, 2022 USD ($) shares | Dec. 31, 2021 USD ($) | Dec. 31, 2020 USD ($) | Aug. 19, 2022 shares | Aug. 08, 2022 shares | Dec. 30, 2021 USD ($)
Investments held at fair value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash purchase of Vor preferred shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 5,000 | $ 500 | $ 1,150 |  |  |
Share of losses recorded against Long Term Interests (LTIs) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 73,703 |  |  |  |
Sale of investments held at fair value |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 118,710 | 218,125 | 350,586 |  |  |
Realized loss on sale of investments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 29,303 | 20,925 | 54,976 |  |  |
Cash Investment (Akili) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 10,000 |  |  |
Loss – change in fair value through profit and loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (32,060) | 179,271 |  |  |  |
Gain on deconsolidation of subsidiary |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 27,251 | 0 | 0 |  |  |
Gelesis |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments held at fair value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share of losses recorded against Long Term Interests (LTIs) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 73,700 | 23,000 |  |  |
Gelesis Earn out shares received in SPAC exchange |  |  | $ 14,214 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gains (losses) on change in fair value of equity investments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (4,400) | 34,600 | 7,100 |  |  |
Number of earnout shares received from SPAC exchange (in shares) | shares |  |  | 4,526,622 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
CapStar Special Purpose Acquisition Corp |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments held at fair value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gelesis Earn out shares received in SPAC exchange |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 100 | 100 |  |  |  |  |
Gains (losses) on earn-out shares at fair value through profit or loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ (14,100) |  |  |  |  |
Vor |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments held at fair value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash purchase of Vor preferred shares |  |  |  |  |  |  |  |  |  | $ 500 |  | $ 500 |  |  |  | $ 700 |  |  |  |  | 500 |  |  |  |
Acquisition of equity instruments in other entities | shares |  |  |  |  |  |  |  |  |  | 961,538 |  | 961,538 |  |  |  |  |  |  |  |  |  |  |  |  |
Share price of investee shares (in dollars per share) |  |  |  |  |  |  |  |  | 18.00 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proportion of ownership interest in investee |  |  |  |  |  |  |  | 8.60% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of equity instruments in other entities (in shares) | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 535,400 | 535,400 |  |  |  |  |
Proceeds from sale of equity investment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ (3,300) |  |  |  |  |  |
Gains (losses) on change in fair value of equity investments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 16,200 | 3,900 | 19,100 |  |  |
Karuna |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments held at fair value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proportion of ownership interest in investee |  |  |  | 5.60% |  |  |  | 8.20% |  |  |  |  |  |  |  |  |  |  |  | 3.10% |  |  |  |  |
Gains (losses) on change in fair value of equity investments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 135,000 | 110,000 | 191,200 |  |  |
Sale of investments held at fair value |  |  |  |  | $ 100,100 |  |  |  | $ 118,000 |  |  |  |  |  |  |  |  | $ 115,500 |  |  |  |  |  |  |
Realized loss on sale of investments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 29,300 |  | 29,303 |  |  |  |  |
Akili |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments held at fair value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Acquisition of equity instruments in other entities | shares | 500,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares held (in shares) | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 12,527,477 |  |
Proportion of ownership interest in investee | 14.70% |  |  |  |  | 27.50% | 41.90% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gelesis Earn out shares received in SPAC exchange |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,000 | 1,000 |  |  |  |  |
Gains (losses) on change in fair value of equity investments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (131,400) | $ 32,200 | 14,400 |  |  |
Cash Investment (Akili) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,000 |  |  |  |  |
Number of earnout shares received from SPAC exchange (in shares) | shares |  |  | 1,433,914 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
resTORbio |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments held at fair value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of investments held at fair value |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 3,000 |  |  |  |  |  |  |  |  |  |  |
Realized loss on sale of investments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 200 |  |  |
Loss – change in fair value through profit and loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 100 |  |  |
Sonde |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments held at fair value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gains (losses) on change in fair value of equity investments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 200 |  |  |  |  |
Fair value of equity investment |  | $ 11,200 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sonde | One Unnamed Investor |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments held at fair value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash purchase of Vor preferred shares |  | $ 3,500 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Acquisition of equity instruments in other entities | shares |  | 1,125,401 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Acquisition of equity instruments in other entities, discount rate |  | 20.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Capstar |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments held at fair value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
SPAC exchange, PIPE transaction, amount |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 15,000
Business combination, investment in common share |  |  | $ 5,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Series A-2 preferred | Vor |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments held at fair value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Acquisition of equity instruments in other entities | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,625,000 |  |  |  |  |  |  |  |  |
Common | Vor |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments held at fair value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued by investee (in shares) | shares |  |  |  |  |  |  |  |  | 9,828,017 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares held (in shares) | shares |  |  |  |  |  |  |  | 3,207,200 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common | Karuna |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments held at fair value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares held (in shares) | shares |  |  |  | 1,656,564 |  |  |  | 2,406,564 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of equity instruments in other entities (in shares) | shares |  |  |  |  | 750,000 |  |  |  | 1,000,000 |  | 1,333,333 |  | 555,500 |  |  |  | 2,100,000 |  |  |  |  |  |  | 125,000 |
Sale of investments held at fair value |  |  |  |  |  |  |  |  |  |  | $ 101,600 |  | $ 45,000 |  |  |  | $ 200,900 |  |  |  |  |  |  |  |
Realized loss on sale of investments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 54,800 |  |  |
Exercise of call options, maximum number of common stocks to be purchased (in shares) | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 477,100 |
Common | resTORbio |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments held at fair value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of equity instruments in other entities (in shares) | shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,119,696 |  |  |  |  |  |  |  |  |  |  |
Series 3 growth preferred stock | Gelesis |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments held at fair value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash purchase of Vor preferred shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 10,000 |  |  |  |  |  |  |  |  |  |
Acquisition of equity instruments in other entities | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 579,038 |  |  |  |  |  |  |  |  |  |
Series D | Akili |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments held at fair value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued by investee (in shares) | shares |  |  |  |  |  | 13,053,508 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from the issuance of shares and subsidiary preferred shares |  |  |  |  |  | $ 110,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

X
- Definition The gains (losses) recognised in association with the loss of control over a subsidiary, which are attributable to the former controlling interest. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2022-03-24 -Paragraph 19 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_19&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_GainsLossesRecognisedWhenControlInSubsidiaryIsLost
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The increase (decrease) in the fair value measurement of assets. [Refer: At fair value [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2022-03-24 -Paragraph 93 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_e&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_IncreaseDecreaseInFairValueMeasurementAssets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The losses on the disposal of investments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2022-03-24 -Paragraph 98 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_98_d&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_LossesOnDisposalsOfInvestments
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash outflow to acquire equity or debt instruments of other entities (other than payments for those instruments considered to be cash equivalents or those held for dealing or trading purposes), classified as investing activities. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 7 -IssueDate 2022-03-24 -Paragraph 16 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16_c&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash inflow from sales of equity or debt instruments of other entities (other than receipts for those instruments considered to be cash equivalents and those held for dealing or trading purposes), classified as investing activities. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 7 -IssueDate 2022-03-24 -Paragraph 16 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16_d&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from issuing shares. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 7 -IssueDate 2022-03-24 -Paragraph 17 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17_a&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_ProceedsFromIssuingShares
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash outflow for the purchase of investments other than investments accounted for using equity method. [Refer: Investments accounted for using equity method; Investments other than investments accounted for using equity method] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 7 -IssueDate 2022-03-24 -Paragraph 16 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Acquisition of equity instruments in other entities + References No definition available. + Details
Name: | ptv_AcquisitionOfEquityInstrumentsInOtherEntities
Namespace Prefix: | ptv_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Acquisition of Equity Instruments In Other Entities, Discount Rate + References No definition available. + Details
Name: | ptv_AcquisitionOfEquityInstrumentsInOtherEntitiesDiscountRate
Namespace Prefix: | ptv_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Exercise Of Call Options, Maximum Number Of Common Stocks To Be Purchased + References No definition available. + Details
Name: | ptv_ExerciseOfCallOptionsMaximumNumberOfCommonStocksToBePurchased
Namespace Prefix: | ptv_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Fair Value Of Equity Investment + References No definition available. + Details
Name: | ptv_FairValueOfEquityInvestment
Namespace Prefix: | ptv_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Financial Investments, Fair Value Of Earnout Shares Received From SPAC Exchange + References No definition available. + Details
Name: | ptv_FinancialInvestmentsFairValueOfEarnoutSharesReceivedFromSPACExchange
Namespace Prefix: | ptv_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Financial Investments, Number Of Earnout Shares Received From SPAC Exchange + References No definition available. + Details
Name: | ptv_FinancialInvestmentsNumberOfEarnoutSharesReceivedFromSPACExchange
Namespace Prefix: | ptv_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Gains (Losses) On Change In Fair Value Of Equity Investments + References No definition available. + Details
Name: | ptv_GainsLossesOnChangeInFairValueOfEquityInvestments
Namespace Prefix: | ptv_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Gains (Losses) On Earn-out Shares At Fair Value Through Profit Or Loss + References No definition available. + Details
Name: | ptv_GainsLossesOnEarnOutSharesAtFairValueThroughProfitOrLoss
Namespace Prefix: | ptv_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Investments held at fair value + References No definition available. + Details
Name: | ptv_InvestmentsHeldAtFairValueLineItems
Namespace Prefix: | ptv_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number Of Shares Held + References No definition available. + Details
Name: | ptv_NumberOfSharesHeld
Namespace Prefix: | ptv_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares issued by investee + References No definition available. + Details
Name: | ptv_NumberOfSharesIssuedByInvestee
Namespace Prefix: | ptv_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Proceeds From Sale Of Equity Investment + References No definition available. + Details
Name: | ptv_ProceedsFromSaleOfEquityInvestment
Namespace Prefix: | ptv_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Proportion of ownership interest in investee + References No definition available. + Details
Name: | ptv_ProportionOfOwnershipInterestInInvestee
Namespace Prefix: | ptv_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition SPAC Exchange, Backstop Agreement, Investment In Common Share + References No definition available. + Details
Name: | ptv_SPACExchangeBackstopAgreementInvestmentInCommonShare
Namespace Prefix: | ptv_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition SPAC Exchange, PIPE Transaction, Amount + References No definition available. + Details
Name: | ptv_SPACExchangePIPETransactionAmount
Namespace Prefix: | ptv_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Sale of equity instruments in other entities + References No definition available. + Details
Name: | ptv_SaleOfEquityInstrumentsInOtherEntities
Namespace Prefix: | ptv_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Share of associate loss recorded against long-term interest + References No definition available. + Details
Name: | ptv_ShareOfAssociateLossRecordedAgainstLongTermInterest
Namespace Prefix: | ptv_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Share price of investee shares + References No definition available. + Details
Name: | ptv_SharePriceOfInvesteeShares
Namespace Prefix: | ptv_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | ifrs-full_SignificantInvestmentsInAssociatesAxis=ptv_GelesisMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=ptv_CapStarSpecialPurposeAcquisitionCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ptv_VorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ptv_KarunaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ptv_AkiliMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ptv_ResTORbioMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ptv_SondeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=ptv_OneUnnamedInvestorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ptv_CapstarMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=ptv_SeriesA2PreferredMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=ptv_Series3GrowthPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=ptv_SeriesDMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=ptv_AkiliMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |